Antibacterial polymeric monomer containing halogenated imidazolium salt and preparation method and application of antibacterial polymeric monomer
By developing antibacterial polymerizable monomers containing halogenated imidazole salt structures, the problems of lack of antibacterial activity in acrylate bone cement and reduced mechanical properties of antibiotic bone cement have been solved, and the effect of imparting long-lasting antibacterial properties to acrylate bone cement has been achieved.
Patent Information
- Application Number
- CN201710370647.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2017-05-23
- Publication Date
- 2017-09-15
- Estimated Expiration
- 2037-05-23
AI Technical Summary
Existing acrylic bone cement lacks antibacterial activity, resulting in the need for revision surgery after infection, which increases patient pain and burden, and antibiotic-containing bone cement has problems with reduced mechanical properties and drug resistance.
Develop antibacterial polymerizable monomers containing halogenated imidazole salt structures, prepared through the reaction of N-hydroxyalkyl imidazole with isocyanylethyl methacrylate and alkyl halides, to generate antibacterial methacrylate monomers for partial replacement Methyl methacrylate gives bone cement long-lasting antibacterial properties.
The antibacterial polymerizable monomer significantly improves the antibacterial performance in acrylic bone cement, can participate in the curing process, prevent infection, and does not affect the mechanical properties of the bone cement.